A connection between antihistamines and opioid overdose? Recent findings from a CDC report suggest diphenhydramine—the active ingredient in many common antihistamines—may be a hidden risk. Alberta changes regulations for high-potency narcotics for opioid use disorderUnder the new rules, high-potency narcotics for opioid use disorder will be distributed by licensed AHS clinics and patients will take them there, witnessed by a health professional. Knee’d: What to tell patients about knee injections for osteoarthritis The growing prevalence of knee osteoarthritis could bring more patients into doctors’ offices, asking for pain relief. Pharmacist email alerts fail to reduce co-prescribing of benzodiazepines and opioids Study examines whether email alerts sent by pharmacists to prescribers and primary care managers reduce co-prescribing of opioids and benzodiazepines. No more mandatory training required for B.C. doctors to prescribe methadone for pain Training was seen as a barrier to access methadone for pain management. Researchers developing dissolving pain-relief implant A Northwestern University-led team of researchers has developed an implant that relieves pain on demand without the use of drugs. QUIZ: Puzzles in chronic pain management How well do you know Canada’s primary-care-focused guideline? Medical orgs sound alarm over reports U.S. patients can't get Methotrexate for arthritis, lupus, cancer Restrictions, fears of use arise as fallout from recent Roe v. Wade decision Gabapentin increasingly involved in drug overdose deaths Nearly 90% of drug overdose deaths in which gabapentin was detected also involved an opioid, particularly illicitly manufactured fentanyl. Limited evidence supports the role of cannabis in pain relief A U.S. federally funded systematic evidence review of 3,000 studies (25 of which had scientifically valid evidence) found that just three products showed evidence providing pain relief. First Previous 6 7 8 9 10 Next Last
